Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Nan Nwe Win"'
Autor:
Nan Nwe Win, Shingo Nakamoto, Myint Myint Sein, Mitsuhiko Moriyama, Tatsuo Kanda, Hiroshi Shirasawa
Publikováno v:
Diseases, Vol 6, Iss 1, p 3 (2017)
Myanmar is adjacent to India, Bangladesh, Thailand, Laos and China. In Myanmar, the prevalence of hepatitis B virus (HBV) infections is 6.5% and accounts for 60% of hepatocellular carcinoma. HBV has nine genotypes that have been identified by molecul
Externí odkaz:
https://doaj.org/article/8da112637aa642d2ad8acd7896d5539f
Autor:
Nan Nwe Win, Shingo Nakamoto, Tatsuo Kanda, Hiroki Takahashi, Azusa Takahashi-Nakaguchi, Shin Yasui, Masato Nakamura, Shuang Wu, Fumio Imazeki, Shigeru Mikami, Osamu Yokosuka, Tohru Gonoi, Hiroshi Shirasawa
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 1, p 172 (2017)
Determination of hepatitis C virus (HCV) genotypes plays an important role in the direct-acting agent era. Discrepancies between HCV genotyping and serotyping assays are occasionally observed. Eighteen samples with discrepant results between genotypi
Externí odkaz:
https://doaj.org/article/bd2d68e2f7784ad8a109fc2e3f48d87d
Autor:
Qisen Li, Weiwei Chen, Shuhan Guo, Akiko Suganami, Shingo Nakamoto, Zheng Tian, Ohno Yoshifumi, Shinji Harada, Hiroshi Shirasawa, Naohisa Isegawa, Yutaka Tamura, Majid Vahed, Ruirong Yi, Kengo Saito, Keisuke Yoshida, Nan Nwe Win, Atsushi Nishida, Xue Ma
Publikováno v:
Oncology Reports. 44:2770-2782
Targeting cell‑cycle regulation to hinder cancer cell proliferation is a promising anticancer strategy. The present study investigated the effects of a novel sulfonamide, CCL113, on cell cycle progression in cancer cell lines (HeLa and HepG2), a no
Autor:
Naoya Kato, Masahiro Ogawa, Shingo Nakamoto, Masato Nakamura, Yutaka Tamura, Shunichi Matsuoka, Hiroaki Okamoto, Osamu Ohara, Akiko Suganami, Osamu Yokosuka, Hiroshi Shirasawa, Mitsuhiko Moriyama, Nan Nwe Win, Tatsuo Kanda
Publikováno v:
Future Virology. 14:399-406
Aim: Zinc and metallothioneins play roles in antiviral activities during viral infection. We previously reported that Japanese rice-koji miso has an antiviral activity against hepatitis A virus (HAV) infection in hepatocytes. Materials, methods & res
Autor:
Yuki Haga, Naoya Kato, Osamu Yokosuka, Masahiro Ogawa, Mitsuhiko Moriyama, Shuang Wu, Hiroshi Shirasawa, Reina Sasaki, Shingo Nakamoto, Nan Nwe Win, Shunichi Matsuoka, Hiroaki Okamoto, Masato Nakamura, Naoki Matsumoto, Tatsuo Kanda
Publikováno v:
International Journal of Medical Sciences
Hepatitis A virus (HAV) infection is a major cause of acute hepatitis including acute liver failure. Hepatitis B infection (HBV) occurs worldwide, with the highest rates in Asian and African countries, and there are several reports that HAV infection
Autor:
Yutaka Tamura, Tatsuo Kanda, Akiko Suganami, Mitsuhiko Moriyama, Nan Nwe Win, Hiroaki Okamoto, Hiroshi Shirasawa, Shingo Nakamoto, Xia Jiang
Publikováno v:
International Journal of Medical Sciences
Hepatitis A virus (HAV) infection is one of the major causes of acute hepatitis and acute liver failure in developing and developed countries. Although effective vaccines for HAV infection are available, outbreaks of HAV infection still cause deaths,
Autor:
NAN NWE, Win
研究科: 千葉大学大学院医学薬学府(先端医学薬学専攻)
学位記番号: 千大院医薬博甲第医1587号
学位記番号: 千大院医薬博甲第医1587号
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::d66f2c15fa98bc747a7fdda3832a37d2
https://opac.ll.chiba-u.jp/da/curator/106468/
https://opac.ll.chiba-u.jp/da/curator/106468/
Autor:
Osamu Yokosuka, Shingo Nakamoto, Hiroshi Shirasawa, Shin Yasui, Nan Nwe Win, Shuang Wu, Tatsuo Kanda, Masato Nakamura, Azusa Takahashi-Nakaguchi, Fumio Imazeki, Tohru Gonoi, Hiroki Takahashi, Shigeru Mikami
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 1, p 172 (2017)
International Journal of Molecular Sciences; Volume 18; Issue 1; Pages: 172
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 18; Issue 1; Pages: 172
International Journal of Molecular Sciences
Determination of hepatitis C virus (HCV) genotypes plays an important role in the direct-acting agent era. Discrepancies between HCV genotyping and serotyping assays are occasionally observed. Eighteen samples with discrepant results between genotypi
Autor:
Masato Nakamura, Hiroaki Okamoto, Nan Nwe Win, Osamu Yokosuka, Hiroshi Shirasawa, Shingo Nakamoto, Tatsuo Kanda
Publikováno v:
Biochemical and biophysical research communications. 483(1)
Although the interaction between host and hepatitis A virus (HAV) factors could lead to severe hepatitis A, the exact mechanism of acute liver failure caused by HAV infection is not yet fully understood. The effects of metabolic diseases such as dysl
Myanmar is adjacent to India, Bangladesh, Thailand, Laos and China. In Myanmar, the prevalence of hepatitis C virus (HCV) infection is 2%, and HCV infection accounts for 25% of hepatocellular carcinoma. In this study, we reviewed the prevalence of HC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c52ad4bb818533a377dc5d50eb0ee01f
https://europepmc.org/articles/PMC4945971/
https://europepmc.org/articles/PMC4945971/